NCT00686049|CompletedDMC
HIV Treatment-Readiness Measure (HTRM) Validation
Validation of the HIV Treatment Readiness Measure (HTRM)
Loading search results
Validation of the HIV Treatment Readiness Measure (HTRM)
Sponsor study identifier
observational
200
2 countries
15
Study Start
May 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2009
Actual (reported)Study Completion
January 2009
Actual (reported)The goal of this study is to assess the reliability of the HIV Treatment Readiness Measure (HTRM) to assist clinicians in: (1) determining whether or not youth living with HIV are ready to initiate HAART and (2) identifying youth who may be in need of additional support services to facilitate their adherence to HAART. The current study will examine the psychometric properties of the HTRM and establish its test-retest reliability over a two week period. If the HTRM is found to be reliable, a subsequent study will examine its predictive validity.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 2009
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 2008
Date type not reportedThis date has not been verified as actual or estimated.
May 27, 2008
Actual (reported)May 29, 2008
Actual (reported)January 2009
Actual (reported)January 2009
Actual (reported)To examine the factor structure and estimate the internal consistency of each factor of the HTRM.
1 year
To estimate the test-retest reliability of the HTRM.
Entry, Week 2
To determine an appropriate system for scoring the HTRM.
1 year
To examine the acceptability of the HTRM.
Entry, Week 2
Participants will complete two audio computer assisted self interviews on laptop computers. This study will also involve the abstraction of participants' viral load and CD4 counts from their medical charts.
HIV-infected, English speaking youth between 13 and 24 years of age who are enrolled in care at an AMTU or collaborating site, not currently on HAART but planning to initiate HAART within the next two months.
Childrens Hospital of Los Angeles
Los Angeles, California, 90027, United States
University of California San Francisco
San Francisco, California, 94117, United States
Childrens National Medical Center
Washington D.C., District of Columbia, 20010-2970, United States
Childrens Diagnostic & Treatment Center, Inc
Fort Lauderdale, Florida, 33316, United States
University of Miami School of Medicine
Miami, Florida, 33101, United States
USF College of Medicine
Tampa, Florida, 33606, United States
Ruth M Rothstein CORE Center/ John H Stroger Jr Hospital
M. Isabel Fernández, Ph.D.
Adolescent Trials Network
200 participants (actual enrollment reported by the registry).
First Submitted
May 27, 2008
First Posted
May 29, 2008
Study Start
May 2008
Date type not reportedThis date has not been verified as actual or estimated.
Integrated Treatment of Marijuana Abuse for HIV+ Youth
Contact the study team to confirm eligibility.
Chicago, Illinois, 60612, United States
Childrens Memorial Hospital
Chicago, Illinois, 60614, United States
Tulane University Health Sciences Center
New Orleans, Louisiana, 70112, United States
University of Maryland Express Mailing Address:
Baltimore, Maryland, 21201, United States
Mount Sinai Medical Center
New York, New York, 10128, United States
Montefiore Medical Center
The Bronx, New York, 10467, United States
The Childrens Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
St Jude Childrens Research Hospital
Memphis, Tennessee, 38105-3678, United States
University of Puerto Rico, Medical Sciences Campus
San Juan, 00936-5067, Puerto Rico
Primary Completion
January 2009
Actual (reported)Study Completion
January 2009
Actual (reported)Last Updated
February 28, 2017
Record last verified: 2016-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: